Circio - Latest News and Information
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Technology Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Sunday recap

NewsDealsSocialBlogsVideosPodcasts
HomeCircio
Circio logo

Circio

0 followers

TRVX

Performance

About Circio

Circio Holding ASA is a biotechnology company focused on developing circular RNA–based medicines and immunotherapy therapies. The company is advancing circular RNA expression systems and the circVec platform to enhance gene therapy for genetic diseases. Its operations encompass research, development, and clinical programs with investor and partnering activities highlighted on its website. Circio presents itself as a leader in deploying circular RNA technology to improve therapeutic outcomes in biotechnology and biopharma contexts.

Recent News

Recent Deals

No recent deals for this company.

Key Team Members

David Winer

Co-Founder & CTO

Richard Lee

Co-Founder & CEO

Ross Geiger

Co-Founder & President

Yoshi Gillaspie

Head of Engineering

Key Facts

HQ Location

Oslo, Norway

Founded

2010

Employees

11 - 50

Status

Public

Website

https://circio.com